Efficacy Study of a Repairing Cream in Atopic Dermatitis
Completed · Not applicable
Conditions studied: Atopic Dermatitis (AD)
In brief
The application of DermControl®, a repair cream based on hyaluronic acid, sh-oligopeptide-1 and polyphenols, in combination with topical corticosteroids, could help to improve epidermal barrier function in patients with atopic dermatitis, improving their symptoms and Quality of Life.
Key facts
- Study ID
- NCT07742241
- Run by
- Instituto de Investigacion Biotecnologica, Farmaceutica y Medicamentos Huerfanos, S.L.
- People needed
- 116
- Starts
- 2023-01-09
- Expected to finish
- 2025-07-31
- Last updated by the study team
- 2026-08-03
Who can join
Age: 2 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients from 2 years of age diagnosed with AD by a dermatologist according to Hanifin and Rajka criteria, with a disease duration of at least six months.
You may not qualify if…
- Presence of any clinical infection in the area designated for measurement.
- History of cancer or immunosuppression.
- Coexisting inflammatory skin conditions such as psoriasis or hidradenitis suppurativa.
Where it is running
- Hospital Universitario Virgen de las Nieves — Granada, Spain
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.